These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
123 related articles for article (PubMed ID: 4292405)
41. mcr-1 and bla Tacão M; Tavares RDS; Teixeira P; Roxo I; Ramalheira E; Ferreira S; Henriques I Emerg Infect Dis; 2017 Aug; 23(8):1419-1421. PubMed ID: 28726622 [TBL] [Abstract][Full Text] [Related]
42. Towards Understanding MCR-like Colistin Resistance. Sun J; Zhang H; Liu YH; Feng Y Trends Microbiol; 2018 Sep; 26(9):794-808. PubMed ID: 29525421 [TBL] [Abstract][Full Text] [Related]
43. [ELECTROPHORETIC BEHAVIOR OF COLIMYCIN AND POLYMYXIN E]. DIMODICA G; MOIRAGHIRUGGENINI A Boll Chim Farm; 1964 Sep; 103():679-80. PubMed ID: 14227291 [No Abstract] [Full Text] [Related]
44. Detection of Colistin-Resistant MCR-1-Positive Escherichia coli by Use of Assays Based on Inhibition by EDTA and Zeta Potential. Esposito F; Fernandes MR; Lopes R; Muñoz M; Sabino CP; Cunha MP; Silva KC; Cayô R; Martins WMBS; Moreno AM; Knöbl T; Gales AC; Lincopan N J Clin Microbiol; 2017 Dec; 55(12):3454-3465. PubMed ID: 28978685 [TBL] [Abstract][Full Text] [Related]
45. [A MICROBIOLOGICAL METHOD FOR THE DETERMINATION OF COLISTIN]. OBOJSKA K; OSTROWSKA D Med Dosw Mikrobiol; 1964; 16():239-43. PubMed ID: 14198040 [No Abstract] [Full Text] [Related]
46. Structure-activity studies on polymyxin derivatives carrying three positive charges only reveal a new class of compounds with strong antibacterial activity. Vaara M; Vaara T; Tyrrell JM Peptides; 2017 May; 91():8-12. PubMed ID: 28300674 [TBL] [Abstract][Full Text] [Related]
47. The distribution and binding of tritiated polymyxin B in the mouse. Jacobson M; Koch A; Kuntzman R; Burchall J J Pharmacol Exp Ther; 1972 Nov; 183(2):433-9. PubMed ID: 4343416 [No Abstract] [Full Text] [Related]
48. Potential Toxicity of Polymyxins in Human Lung Epithelial Cells. Ahmed MU; Velkov T; Lin YW; Yun B; Nowell CJ; Zhou F; Zhou QT; Chan K; Azad MAK; Li J Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28416543 [TBL] [Abstract][Full Text] [Related]
49. Pharmacologic and toxicologic studies with the polymyxins. 3. Consideration regarding clinical use in dogs. al-Khayyat AA; Aronson AL Chemotherapy; 1973; 19(2):98-108. PubMed ID: 4357725 [No Abstract] [Full Text] [Related]
50. Comparative study of the effect of three antibiotics on renal function. Caldwell AD; Martin AJ; Trigger DJ Br J Pharmacol; 1969 Sep; 37(1):283-93. PubMed ID: 4310020 [TBL] [Abstract][Full Text] [Related]
51. Small molecule adjuvants that suppress both chromosomal and mcr-1 encoded colistin-resistance and amplify colistin efficacy in polymyxin-susceptible bacteria. Barker WT; Martin SE; Chandler CE; Nguyen TV; Harris TL; Goodell C; Melander RJ; Doi Y; Ernst RK; Melander C Bioorg Med Chem; 2017 Oct; 25(20):5749-5753. PubMed ID: 28958847 [TBL] [Abstract][Full Text] [Related]
52. Polymyxins in 2015: it's like déjà vu all over again. Pogue JM; Rotschafer JC Pharmacotherapy; 2015 Jan; 35(1):9-10. PubMed ID: 25630410 [No Abstract] [Full Text] [Related]
53. [On the use of some new antibiotics in the therapy of neonatal infections due to gram-negative bacilli. II. Bacteriologic studies]. Rosaschino F; Flaúto U; Marini A Minerva Pediatr; 1967 Sep; 19(38):1763-6. PubMed ID: 4305801 [No Abstract] [Full Text] [Related]
54. [BACTERICIDAL ACTIVITY OF THE OXYTETRACYCLINE-POLYMYXIN COMBINATION]. LAPLOSSOTTE J; FERRABOUC L Therapie; 1963; 18():915-20. PubMed ID: 14069330 [No Abstract] [Full Text] [Related]
55. An Improved Medium for Colistin Susceptibility Testing. Gwozdzinski K; Azarderakhsh S; Imirzalioglu C; Falgenhauer L; Chakraborty T J Clin Microbiol; 2018 May; 56(5):. PubMed ID: 29514937 [TBL] [Abstract][Full Text] [Related]
56. Polymorphism of genes encoding PmrAB in colistin-resistant strains of Escherichia coli and Salmonella enterica isolated from poultry and swine. Quesada A; Porrero MC; Téllez S; Palomo G; García M; Domínguez L J Antimicrob Chemother; 2015 Jan; 70(1):71-4. PubMed ID: 25150146 [TBL] [Abstract][Full Text] [Related]
57. Are there any ways around the exposure-limiting nephrotoxicity of the polymyxins? Pogue JM; Ortwine JK; Kaye KS Int J Antimicrob Agents; 2016 Dec; 48(6):622-626. PubMed ID: 27876274 [TBL] [Abstract][Full Text] [Related]
59. [Basic study on chemotherapy of urinary tract infection. II. Effect of urine pH on antibacterial activity of chemotherapeutics on Escherichia coli]. Igari J; Kondo H; Kudo M; Kano M Jpn J Antibiot; 1968 Jun; 21(3):118-23. PubMed ID: 4301952 [No Abstract] [Full Text] [Related]
60. [BACTERICIDAL EFFECT OF COMBINED ANTIBIOTICS AGAINST ENTEROBACTERIACEAE AND PSEUDOMONADACEAE]. CLUZEL R; VAURS R; CLUZEL-NIGAY M; MICHEL J Pathol Biol; 1964 Jan; 12():47-51. PubMed ID: 14133426 [No Abstract] [Full Text] [Related] [Previous] [Next] [New Search]